Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for cancer.

A B Miller

    The Western Journal of Medicine
    |December 1, 1988
    PubMed
    Summary
    This summary is machine-generated.

    Effective cancer screening is limited to breast and cervical cancers. Mammograms are recommended for women aged 50-70, while cervical screening should target sexually active women aged 25-60.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Impact of blue light therapy on plasma adrenocorticotropic hormone (ACTH) and hypertrichosis in horses with pituitary pars intermedia dysfunction.

    Domestic animal endocrinology·2021
    Same author

    Effects of pituitary pars intermedia dysfunction and Prascend (pergolide tablets) treatment on endocrine and immune function in horses.

    Domestic animal endocrinology·2020
    Same author

    Reply to Are cohort data on smokeless tobacco use and pancreatic cancer confounded by alcohol use?

    Annals of oncology : official journal of the European Society for Medical Oncology·2020
    Same author

    The role of screening mammography in the era of modern breast cancer treatment.

    Climacteric : the journal of the International Menopause Society·2018
    Same author

    The OncoSim model: development and use for better decision-making in Canadian cancer control.

    Current oncology (Toronto, Ont.)·2017
    Same author

    Implementing low-dose computed tomography screening for lung cancer in Canada: implications of alternative at-risk populations, screening frequency, and duration.

    Current oncology (Toronto, Ont.)·2016
    Same journal

    Does daily use of sunscreen or beta-carotene supplements prevent skin cancer in healthy adults?

    The Western journal of medicine·2008
    Same journal

    [Not Available].

    The Western journal of medicine·2008
    Same journal

    [Not Available].

    The Western journal of medicine·2008
    Same journal

    [Not Available].

    The Western journal of medicine·2008
    Same journal

    [Not Available].

    The Western journal of medicine·2008
    Same journal

    [Not Available].

    The Western journal of medicine·2008
    See all related articles

    Area of Science:

    • Oncology
    • Preventive Medicine
    • Public Health

    Background:

    • Screening is a cornerstone of cancer prevention and early detection.
    • The effectiveness of cancer screening varies significantly by cancer type and target population.
    • Current clinical practice guidelines emphasize evidence-based screening strategies.

    Purpose of the Study:

    • To evaluate the efficacy of different cancer screening modalities.
    • To define optimal screening protocols for breast and cervical cancers.
    • To assess the potential impact of screening on overall cancer mortality.

    Main Methods:

    • Review of current evidence on screening effectiveness for various cancer sites.
    • Analysis of age, frequency, and modality recommendations for breast cancer screening (mammography, self-examination, physical examination).

    Related Experiment Videos

  • Analysis of age, frequency, and risk factors for cervical cancer screening (Pap test).

    • Main Results:

    • Mammographic screening every two years from age 50 to 70 is justified for breast cancer.
    • Breast self-examination and physical examination may benefit women over 40.
    • Screening sexually active women aged 25-60 every three years is highly effective for cervical cancer.
    • Colorectal cancer screening methods (sigmoidoscopy, fecal occult blood tests) remain experimental.
    • Organizational challenges hinder the immediate impact of screening programs on overall cancer mortality.

    Conclusions:

    • Routine clinical practice should include screening for breast and cervical cancers based on established evidence.
    • Optimized screening programs, if implemented effectively, hold significant potential for reducing breast and cervical cancer mortality.
    • Further research and organizational improvements are necessary to maximize the benefits of cancer screening.